Facet browsing currently unavailable
Page 3 of 3756 results
Sort by: relevance publication year
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance JOURNAL ARTICLE published July 2021 in Cancer Cell |
Single-chromosome Gains Commonly Function as Tumor Suppressors JOURNAL ARTICLE published February 2017 in Cancer Cell Research funded by NIH (P30-CA14051,GM056800) |
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia JOURNAL ARTICLE published January 2016 in Cancer Cell |
Mitogen requirement for cell cycle progression in the absence of pocket protein activity JOURNAL ARTICLE published December 2005 in Cancer Cell |
Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase JOURNAL ARTICLE published January 2018 in Cancer Cell Research funded by American Cancer Society (PF-12-189-01) | National Cancer Institute (4R01CA129562,CA09302) |
Location, Location, Location: FoxM1 Mediates β-Catenin Nuclear Translocation and Promotes Glioma Tumorigenesis JOURNAL ARTICLE published October 2011 in Cancer Cell |
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells JOURNAL ARTICLE published June 2004 in Cancer Cell |
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma JOURNAL ARTICLE published December 2011 in Cancer Cell |
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach JOURNAL ARTICLE published October 2004 in Cancer Cell |
CREPT Accelerates Tumorigenesis by Regulating the Transcription of Cell-Cycle-Related Genes JOURNAL ARTICLE published January 2012 in Cancer Cell |
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies JOURNAL ARTICLE published June 2022 in Cancer Cell |
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial JOURNAL ARTICLE published July 2021 in Cancer Cell |
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer JOURNAL ARTICLE published February 2022 in Cancer Cell |
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma JOURNAL ARTICLE published June 2021 in Cancer Cell |
New Views into the Genetic Landscape of Metastatic Breast Cancer JOURNAL ARTICLE published August 2017 in Cancer Cell |
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia JOURNAL ARTICLE published April 2024 in Cancer Cell Research funded by National Institutes of Health (R01 CA203108,R01 CA247234,P30 CA225520,R01 CA186338) |
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance JOURNAL ARTICLE published January 2020 in Cancer Cell Research funded by Cancer Research UK (C33043/A12065,C33043/A24478,C30122/A11527,C30122/A15774,C33043/A12065,C107/A10433,C107/A104339) | Royal Society (RG110591) | Marie Sklodowska-Curie Action (H2020-MSCA-IF-2014-EF-ST,MR/L023091/1) | CRUK (C10355/A15587) | CRUK (FC001112) | MRC (FC001112) | Wellcome Trust (FC001112) | NIHR Biomedical Research Centre (IS-BRC-1215-20006) |
Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer JOURNAL ARTICLE published May 2007 in Cancer Cell |
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways JOURNAL ARTICLE published March 2019 in Cancer Cell Research funded by BBSRC (BB/R009295/1) | PCUK (MA-TR15-009) | Medical Research Council (MR/M025411/1) | Wellcome Trust (FC001202) | Medical Research Council (FC001202) |
A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion JOURNAL ARTICLE published February 2019 in Cancer Cell Research funded by NCI (1R01 CA21673-01,1R01 CA155010-01A1,1U10 CA180861-01) | NHLBI (1R01 HL103532-01,1R01 HL116452-01,ZIA HL002346-13) | NIH (R01 DK087992,P01 CA81534,5P30 CA006516,R35 GM122524) | US Public Health Service (R01 CA63113,R01 CA173023,P01 CA203655) | National Science Foundation (DGE1144152) |